Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Schmidt

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Viruses|May 27, 2023
Risk Factors in HIV-1 Positive Patients on the Intensive Care Unit: A Single Center Experience from a Tertiary Care HospitalArik Bernard Schulze, Michael Mohr, Jan Sackarnd, et al.
Scientific Reports|July 19, 2018
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancerAndreas Kuemmel, Astrid Alflen, Lars Henning Schmidt, et al.
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]|August 18, 2017
Let's do this together: Bi-Manu-Interact, a novel device for studying human haptic interactive behaviorEkaterina Ivanova, Axel Krause, Marie Schalicke, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 9, 2008
The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Innovative Surgical Sciences|January 28, 2021
Intrauterine negative-pressure therapy (IU-NPT) to treat peritonitis after caesarean sectionChris-Henrik Wulfert, Christian Theodor Müller, Ahmed Farouk Abdel-Kawi, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancerArik Bernard Schulze, Georg Evers, Dennis Görlich, et al.
Pharmacology Research & Perspectives|April 28, 2025
Population Pharmacokinetics of Osimertinib in Patients With Non-Small Cell Lung CancerMartin Johnson, Yu-Wei Lin, Henning Schmidt, et al.
British Journal of Clinical Pharmacology|August 19, 2024
Exposure-response modelling of osimertinib in patients with non-small cell lung cancerMartin Johnson, Yu-Wei Lin, Henning Schmidt, et al.
Canadian Respiratory Journal|June 23, 2020
Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center ExperienceGeorg Evers, Arik Bernard Schulze, Michael Thrull, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
TA-MUC1 epitope in non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Viruses|May 27, 2023
Risk Factors in HIV-1 Positive Patients on the Intensive Care Unit: A Single Center Experience from a Tertiary Care HospitalArik Bernard Schulze, Michael Mohr, Jan Sackarnd, et al.
Scientific Reports|July 19, 2018
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancerAndreas Kuemmel, Astrid Alflen, Lars Henning Schmidt, et al.
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]|August 18, 2017
Let's do this together: Bi-Manu-Interact, a novel device for studying human haptic interactive behaviorEkaterina Ivanova, Axel Krause, Marie Schalicke, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 9, 2008
The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Innovative Surgical Sciences|January 28, 2021
Intrauterine negative-pressure therapy (IU-NPT) to treat peritonitis after caesarean sectionChris-Henrik Wulfert, Christian Theodor Müller, Ahmed Farouk Abdel-Kawi, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancerArik Bernard Schulze, Georg Evers, Dennis Görlich, et al.
Pharmacology Research & Perspectives|April 28, 2025
Population Pharmacokinetics of Osimertinib in Patients With Non-Small Cell Lung CancerMartin Johnson, Yu-Wei Lin, Henning Schmidt, et al.
British Journal of Clinical Pharmacology|August 19, 2024
Exposure-response modelling of osimertinib in patients with non-small cell lung cancerMartin Johnson, Yu-Wei Lin, Henning Schmidt, et al.
Canadian Respiratory Journal|June 23, 2020
Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center ExperienceGeorg Evers, Arik Bernard Schulze, Michael Thrull, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
TA-MUC1 epitope in non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Pageof 8